[28 June/The Country]

Auckland start-up, PharmaCann, signed a deal with the Auckland University of Technology in a bid to produce cheaper locally made medicinal cannabis. Pharmacann hoped the partnership would help develop high quality cannabis products that were a fraction of the price of existing cannabis medicines in New Zealand. Founder, Chris Fowlie, was confident clinical trials could be underway by the time a new law for medical cannabis comes into force. He said for patients it meant access to cannabis based products would be quicker and cheaper. They have applied for a licence from the Ministry of Health while the law change goes through Parliament. The new law would allow a wide range of cannabis products to be prescribed. Mr Fowlie noted they believed if they had a herbal remedy or natural health supplements approach they could bring products to market at around 1 percent of the cost of Sativex.